Cargando…

Identifying components for programmatic latent tuberculosis infection control in the European Union

Individuals with latent tuberculosis infection (LTBI) are the reservoir of Mycobacterium tuberculosis in a population and as long as this reservoir exists, elimination of tuberculosis (TB) will not be feasible. In 2013, the European Centre for Disease Prevention and Control (ECDC) started an assessm...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandgren, Andreas, Vonk Noordegraaf-Schouten, Jannigje M, Oordt-Speets, Anouk M, van Kessel, Gerarda B, de Vlas, Sake J, van der Werf, Marieke J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5144935/
https://www.ncbi.nlm.nih.gov/pubmed/27589214
http://dx.doi.org/10.2807/1560-7917.ES.2016.21.34.30325
_version_ 1782473206661120000
author Sandgren, Andreas
Vonk Noordegraaf-Schouten, Jannigje M
Oordt-Speets, Anouk M
van Kessel, Gerarda B
de Vlas, Sake J
van der Werf, Marieke J
author_facet Sandgren, Andreas
Vonk Noordegraaf-Schouten, Jannigje M
Oordt-Speets, Anouk M
van Kessel, Gerarda B
de Vlas, Sake J
van der Werf, Marieke J
author_sort Sandgren, Andreas
collection PubMed
description Individuals with latent tuberculosis infection (LTBI) are the reservoir of Mycobacterium tuberculosis in a population and as long as this reservoir exists, elimination of tuberculosis (TB) will not be feasible. In 2013, the European Centre for Disease Prevention and Control (ECDC) started an assessment of benefits and risks of introducing programmatic LTBI control, with the aim of providing guidance on how to incorporate LTBI control into national TB strategies in European Union/European Economic Area (EU/EEA) Member States and candidate countries. In a first step, experts from the Member States, candidate countries, and international and national organisations were consulted on the components of programmatic LTBI control that should be considered and evaluated in literature reviews, mathematical models and cost-effectiveness studies. This was done through a questionnaire and two interactive discussion rounds. The main components identified were identification and targeting of risk groups, determinants of LTBI and progression to active TB, optimal diagnostic tests for LTBI, effective preventive treatment regimens, and to explore the potential for combining LTBI control with other health programmes. Political commitment, a solid healthcare infrastructure, and favourable economic situation in specific countries were identified as essential to facilitate the implementation of programmatic LTBI control.
format Online
Article
Text
id pubmed-5144935
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher European Centre for Disease Prevention and Control (ECDC)
record_format MEDLINE/PubMed
spelling pubmed-51449352016-12-12 Identifying components for programmatic latent tuberculosis infection control in the European Union Sandgren, Andreas Vonk Noordegraaf-Schouten, Jannigje M Oordt-Speets, Anouk M van Kessel, Gerarda B de Vlas, Sake J van der Werf, Marieke J Euro Surveill Perspective Individuals with latent tuberculosis infection (LTBI) are the reservoir of Mycobacterium tuberculosis in a population and as long as this reservoir exists, elimination of tuberculosis (TB) will not be feasible. In 2013, the European Centre for Disease Prevention and Control (ECDC) started an assessment of benefits and risks of introducing programmatic LTBI control, with the aim of providing guidance on how to incorporate LTBI control into national TB strategies in European Union/European Economic Area (EU/EEA) Member States and candidate countries. In a first step, experts from the Member States, candidate countries, and international and national organisations were consulted on the components of programmatic LTBI control that should be considered and evaluated in literature reviews, mathematical models and cost-effectiveness studies. This was done through a questionnaire and two interactive discussion rounds. The main components identified were identification and targeting of risk groups, determinants of LTBI and progression to active TB, optimal diagnostic tests for LTBI, effective preventive treatment regimens, and to explore the potential for combining LTBI control with other health programmes. Political commitment, a solid healthcare infrastructure, and favourable economic situation in specific countries were identified as essential to facilitate the implementation of programmatic LTBI control. European Centre for Disease Prevention and Control (ECDC) 2016-08-25 /pmc/articles/PMC5144935/ /pubmed/27589214 http://dx.doi.org/10.2807/1560-7917.ES.2016.21.34.30325 Text en This article is copyright of ECDC, 2016. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.
spellingShingle Perspective
Sandgren, Andreas
Vonk Noordegraaf-Schouten, Jannigje M
Oordt-Speets, Anouk M
van Kessel, Gerarda B
de Vlas, Sake J
van der Werf, Marieke J
Identifying components for programmatic latent tuberculosis infection control in the European Union
title Identifying components for programmatic latent tuberculosis infection control in the European Union
title_full Identifying components for programmatic latent tuberculosis infection control in the European Union
title_fullStr Identifying components for programmatic latent tuberculosis infection control in the European Union
title_full_unstemmed Identifying components for programmatic latent tuberculosis infection control in the European Union
title_short Identifying components for programmatic latent tuberculosis infection control in the European Union
title_sort identifying components for programmatic latent tuberculosis infection control in the european union
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5144935/
https://www.ncbi.nlm.nih.gov/pubmed/27589214
http://dx.doi.org/10.2807/1560-7917.ES.2016.21.34.30325
work_keys_str_mv AT sandgrenandreas identifyingcomponentsforprogrammaticlatenttuberculosisinfectioncontrolintheeuropeanunion
AT vonknoordegraafschoutenjannigjem identifyingcomponentsforprogrammaticlatenttuberculosisinfectioncontrolintheeuropeanunion
AT oordtspeetsanoukm identifyingcomponentsforprogrammaticlatenttuberculosisinfectioncontrolintheeuropeanunion
AT vankesselgerardab identifyingcomponentsforprogrammaticlatenttuberculosisinfectioncontrolintheeuropeanunion
AT devlassakej identifyingcomponentsforprogrammaticlatenttuberculosisinfectioncontrolintheeuropeanunion
AT vanderwerfmariekej identifyingcomponentsforprogrammaticlatenttuberculosisinfectioncontrolintheeuropeanunion